Literature DB >> 11176048

Basal cell carcinomas are populated by melanocytes and Langerhans [correction of Langerhan's] cells.

S R Florell1, J J Zone, J W Gerwels.   

Abstract

Several reports have documented the coexistence of basal cell carcinoma (BCC) with other lesions, including melanoma. This study was performed to determine whether nests of BCC contain benign melanocytes and Langerhans [corrected] cells. Ten cases of BCC were investigated to determine whether benign melanocytes and Langerhans [corrected] cells populate tumor nests. The BCCs were stained with antibodies to cytokeratin AEI/AE3, S-100, HMB-45, Melan-A, and CD1a proteins. We report that all 10 BCCs were populated by dendritic melanocytes distributed at the periphery (5/10 cases) or evenly throughout tumor nests (5/10 cases). Clusters of melanocytes were not identified in any of the BCCs. A total of 9 of 10 tumors showed staining of dendritic Langerhans cells with CD1a. A total of 8 of 10 tumors stained with cytokeratin AEI/AE3; in 6 of the 8 tumors, the staining was focal. We compared these findings with a single example of a BCC and melanoma in situ (MIS) collision tumor in which the cytokeratin AE1/AE3-positive epithelial nests of BCC were populated by a high density of malignant melanocytes that stained with S-100 and HMB-45. Melanocytes were disposed singly and in clusters of two or more cells within BCC tumor nests. We conclude from this study that BCCs are regularly populated by benign melanocytes and Langerhans [corrected] cells. Furthermore, when BCC is infiltrated with malignant melanocytes of MIS, the melanocyte density is higher and clusters of melanocytes can be observed. The significance of these two findings is unclear, as additional cases of BCC MIS collision tumor need to be studied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176048     DOI: 10.1097/00000372-200102000-00004

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  7 in total

1.  Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.

Authors:  Markku Miettinen; Peter A McCue; Maarit Sarlomo-Rikala; Wojciech Biernat; Piotr Czapiewski; Janusz Kopczynski; Lester D Thompson; Jerzy Lasota; Zengfeng Wang; John F Fetsch
Journal:  Am J Surg Pathol       Date:  2015-06       Impact factor: 6.394

2.  Dermoscopic features of basal cell carcinoma in skin of color: A retrospective cross-sectional study from Puducherry, South India.

Authors:  Biswanath Behera; Rashmi Kumari; Devinder Mohan Thappa; Debasis Gochhait; Bheemanathi Hanuman Srinivas; Pavithra Ayyanar
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021-04-23       Impact factor: 2.545

3.  Pigmentation, Melanocyte Colonization, and p53 Status in Basal Cell Carcinoma.

Authors:  Lídia M Frey; Roland Houben; Eva-B Bröcker
Journal:  J Skin Cancer       Date:  2010-09-29

Review 4.  Pigmented extramammary Paget's disease of the axilla mimicking melanoma: case report and review of the literature.

Authors:  Nicholaus J Hilliard; Conway Huang; Aleodor Andea
Journal:  J Cutan Pathol       Date:  2009-09       Impact factor: 1.587

5.  Pigmented squamous cell carcinoma: case report and importance of differential diagnosis.

Authors:  Patrícia Motta de Morais; Antônio Pedro Mendes Schettini; Jeanine Alvarenga Rocha; Renato Cândido da Silva Júnior
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

6.  Colonisation of basal cell carcinoma and actinic keratosis by malignant melanoma in situ in a patient with xeroderma pigmentosum variant.

Authors:  Louise J Smith; Ehab A Husain
Journal:  Clin Pract       Date:  2012-04-16

Review 7.  Melanoma in situ colonizing basal cell carcinoma: a case report and review of the literature.

Authors:  Silvia E Mancebo; Michael A Marchetti; Travis J Hollmann; Ashfaq A Marghoob; Klaus J Busam; Allan C Halpern
Journal:  Dermatol Pract Concept       Date:  2015-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.